Montenarh, D; Hopf, M; Warth, S; Maurer, HH; Schmidt, P; Ewald, AH. A simple extraction and LC-MS/MS approach for the screening and identification of over 100 analytes in eight different matrices: Detection of 130 analytes in eight biosamples using only one LC-MS/MS method. Drug Test. Analysis, 1 Mar 2015, 7 (3), 214-240. 593 kB. https://doi.org/10.1002/dta.1657
Currie, KS. Antianxiety Agents. In Burger's Medicinal Chemistry and Drug Discovery; Abraham, DJ, Ed., John Wiley & Sons, Inc., 15 Jan 2003; pp 525–597. 2.7 MB. https://doi.org/10.1002/0471266949.bmc102 #1
Hudkins, RL; Marino, MJ; Williams, M. Cognition. In Burger's Medicinal Chemistry and Drug Discovery; Abraham, DJ, Ed., John Wiley & Sons, Inc., 29 Jan 2010; pp 15–60. 784 kB. https://doi.org/10.1002/0471266949.bmc242 #94
Chambers, SA; DeSousa, JM; Huseman, ED; Townsend, SD. The DARK side of total synthesis: Strategies and tactics in psychoactive drug production. ACS Chem. Neurosci., 17 Oct 2018, 9 (10), 2307–2330. 8.1 MB. https://doi.org/10.1021/acschemneuro.7b00528 #101
Cappelli, A; Anzini, M; Castriconi, F; Grisci, G; Paolino, M; Braile, C; Biggio, G. Design, synthesis, and biological evaluation of imidazo[1,5-a]quinoline as highly potent ligands of central benzodiazepine receptors. J. Med. Chem., 14 Apr 2016, 59 (7), 3353–3372. 3.0 MB. https://doi.org/10.1021/acs.jmedchem.6b00034 #1 MS,NMR
Huang, Q; He, X; Ma, C; Liu, R; Yu, S; Dayer, CA; Wenger, GR; McKernan, R; Cook, JM. Pharmacophore/receptor models for GABAA/BzR subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a comprehensive ligand-mapping approach. J. Med. Chem., 1 Jan 2000, 43 (1), 71–95. 912 kB. https://doi.org/10.1021/jm990341r #145